Skip to main content
SpringerLink
Log in

Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Peritoneal mesothelioma is a rare disease with few therapeutic options. Recently, the combination of cytoreductive surgery with intraperitoneal hyperthermic chemotherapy (HIPEC) has shown promising results.

Methods

Fifteen patients with peritoneal mesothelioma who were treated by cytoreductive surgery and HIPEC between 1989 and 2004 were identified from a prospective database. HIPEC was performed with cisplatin and mitomycin C for 90 minutes by using the closed-abdomen technique.

Results

All patients but one (multicystic) had malignant disease of the following pathologic types: 12 epithelial and 2 biphasic. After surgical resection, 11 patients were considered to have a CC-0 or CC-1 resection (macroscopic complete resection or diameter of residual nodules <2.5 mm). No postoperative death occurred, and six postoperative complications were recorded. All but one patient had resolution of ascites. The overall median survival for the 14 patients with malignant mesothelioma was 35.6 months. The median survival was 37.8 months for patients treated with a CC-0 or CC-1 resection, whereas it was 6.5 months for those treated with a CC-2 or CC-3 resection (diameter of residual nodules >2.5 mm; P < .001). In a univariate analysis, the only other significant prognostic factor was the carcinomatosis extent (P = .02).

Conclusions

A therapeutic strategy combining cytoreductive surgery with HIPEC seems to provide an adequate and efficient locoregional treatment for peritoneal mesothelioma. It is associated with acceptable morbidity when performed by an experienced surgical team. The completeness of cytoreduction is the major determinant of survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig 2

Similar content being viewed by others

References

  1. Antman K, Shemin R, Ryan L, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 1988;6:147–53

    CAS  PubMed  Google Scholar 

  2. Asensio JA, Goldblatt P, Thomford NR. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch Surg 1990;125:1477–81

    CAS  PubMed  Google Scholar 

  3. Neumann V, Rutten A, Scharmach M, Muller KM, Fischer M. Factors influencing long-term survival in mesothelioma patients—results of the German mesothelioma register. Int Arch Occup Environ Health 2004;77:191–9

    Article  CAS  PubMed  Google Scholar 

  4. Peterson JT Jr, Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma. A review. Cancer 1984;54:951–60

    PubMed  Google Scholar 

  5. Sugarbaker PH, Welch L, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin North Am 2003;12:605–21

    Google Scholar 

  6. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003;21:4560–7

    Article  CAS  PubMed  Google Scholar 

  7. Acherman YI, Welch LS, Bromley CM, Sugarbaker PH. Clinical presentation of peritoneal mesothelioma. Tumori 2003;89:269–73

    PubMed  Google Scholar 

  8. Antman KH, Blum RH, Greenberger JS, et al. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980;68:356–62

    Article  CAS  PubMed  Google Scholar 

  9. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29–42

    CAS  PubMed  Google Scholar 

  10. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 2004;5:219–28

    Article  PubMed  Google Scholar 

  11. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437–44

    CAS  PubMed  Google Scholar 

  12. Elias D, Pocard M. Treatment and prevention of peritoneal carcinomatosis from colorectal cancer. Surg Clin North Am 2003;12:543–59

    Google Scholar 

  13. Crile G. The effect of heat and radiation on cancers implanted in the feet of mice. Cancer Res 1963;23:372–80

    PubMed  Google Scholar 

  14. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 1998;14:254–61

    Article  CAS  PubMed  Google Scholar 

  15. Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res 1980;40:1165–8

    CAS  PubMed  Google Scholar 

  16. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096–9

    CAS  PubMed  Google Scholar 

  17. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 2003;21:799–806

    Article  CAS  PubMed  Google Scholar 

  18. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998;69:103–8

    Article  CAS  PubMed  Google Scholar 

  19. Ruth S, Verwaal VJ, Hart AA, van Slooten GW, Zoetmulder FA. Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy. Anticancer Res 2003;23:1501–8

    PubMed  Google Scholar 

  20. Loggie BW, Fleming RA, McQuellon RP, et al. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 2001;67:999–1003

    CAS  PubMed  Google Scholar 

  21. Deraco M, Casali P, Inglese MG, et al. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 2003;83:147–53

    Article  PubMed  Google Scholar 

  22. Gilly FN, Carry PY, Sayag AC, et al. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994;41:124–9

    CAS  PubMed  Google Scholar 

  23. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–31

    Article  CAS  PubMed  Google Scholar 

  24. Treasure T, Sedrakyan A. Pleural mesothelioma: little evidence, still time to do trials. Lancet 2004;364:1183–5

    Article  PubMed  Google Scholar 

  25. Averbach AM, Sugarbaker PH. Peritoneal mesothelioma: treatment approach based on natural history. Cancer Treat Res 1996;81:193–211

    CAS  PubMed  Google Scholar 

  26. Wagner JC, Sleegs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260–71

    CAS  PubMed  Google Scholar 

  27. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001;357:444–5

    CAS  PubMed  Google Scholar 

  28. Mohamed F, Sugarbaker PH. Peritoneal mesothelioma. Curr Treat Options Oncol 2002;3:375–86

    PubMed  Google Scholar 

  29. Sridhar KS, Doria R, Raub WA Jr, Thurer RJ, Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer 1992;70:2969–79

    CAS  PubMed  Google Scholar 

  30. Rose RG, Palmer JD, Lougheed MN. Treatment of peritoneal mesothelioma with radioactive colloidal gold; report of a case. Cancer 1955;8:478–81

    CAS  PubMed  Google Scholar 

  31. Rogoff EE, Hilaris BS, Huvos AG. Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation. Cancer 1973;32:656–64

    CAS  PubMed  Google Scholar 

  32. Markman M, Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 1992;118:547–50

    CAS  PubMed  Google Scholar 

  33. Langer CJ, Rosenblum N, Hogan M, et al. Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach. Cancer Chemother Pharmacol 1993;32:204–8

    Article  CAS  PubMed  Google Scholar 

  34. Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 2000;87:1587–93

    Article  CAS  PubMed  Google Scholar 

  35. Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999;70:6–12

    Article  CAS  PubMed  Google Scholar 

  36. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004;22:3284–92

    Article  CAS  PubMed  Google Scholar 

  37. Barakat RR, Sabbatini P, Bhaskaran D, et al. Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol 2002;20:694–8

    Article  PubMed  Google Scholar 

  38. Sugarbaker PH, Mora JT, Carmignani P, Stuart OA, Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 2005;10:112–22

    Article  CAS  PubMed  Google Scholar 

  39. Sayag AC, Gilly FN, Carry PY, et al. Intraoperative chemohyperthermia in the management of digestive cancers. A general review of literature. Oncology 1993;50:333–7

    CAS  PubMed  Google Scholar 

  40. Glehen O, Osinski D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003;10:863–9

    Article  CAS  PubMed  Google Scholar 

  41. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790–6

    Article  CAS  PubMed  Google Scholar 

  42. Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 2005;103:839–49

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France

    C. Brigand MD

  2. Department of Emergency Surgery, Hôpital Edouard Herriot, Lyon, France

    O. Monneuse MD

  3. Equipe Accueil 3738, Faculté de Médecine Lyon-Sud, Oullins, France

    O. Monneuse MD, F. N. Gilly MD, PhD & O. Glehen MD, PhD

  4. Department of General Surgery, Newcastle upon Tyne, United Kingdom

    F. Mohamed MBChB, MRCS

  5. Department of Anesthesiology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France

    A. C. Sayag-Beaujard MD

  6. Department of Pathology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France

    S. Isaac MD

  7. Department of Surgical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Bénite Cédex, 69495, France

    F. N. Gilly MD, PhD & O. Glehen MD, PhD

Authors
  1. C. Brigand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Monneuse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Mohamed MBChB, MRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. C. Sayag-Beaujard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Isaac MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. N. Gilly MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. Glehen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Glehen MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brigand, C., Monneuse, O., Mohamed, F. et al. Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study. Ann Surg Oncol 13, 405–412 (2006). https://doi.org/10.1245/ASO.2006.05.041

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2006.05.041

Keywords

Search

Navigation